Skip to main content

Table 3 Clinical and demographical characteristic of the additional validation set of patients (4 CIS and 6 Definite MS).

From: Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells

  Age (Years) Disease Duration (Years) Annua Relapse Rate EDSS F/M Yes/No Future IMD Treatment
CIS 24 ± 5.01 0.34 ± 0.09 6.1 ± 2.05 2.58 ± 0.15 0/6 6/0
Definite MS 36 ± 7.61 5.3 ± 2.39 1 ± 0.51 5.3 ± 2.39 2/2 3/1